MedPath

IBSA Institut Biochimique SA

IBSA Institut Biochimique SA logo
🇳🇱Netherlands
Ownership
Private
Established
1945-01-01
Employees
1K
Market Cap
-
Website
http://www.ibsagroup.com

Progesterone in Threatened Abortion

Phase 3
Terminated
Conditions
Threatened Abortion in First Trimester
Interventions
Drug: Placebo
Drug: Progesterone
First Posted Date
2016-11-01
Last Posted Date
2018-07-20
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
4
Registration Number
NCT02950935
Locations
🇮🇹

P.O.G. Salesi, Ancona, Italy

🇮🇹

Presidio Ospedale S'Anna, Torino, Italy

🇮🇹

"F. Miulli" Regional General Hospital, Bari, BA, Italy

and more 1 locations

Progesterone in Luteal Phase Deficiency

Phase 3
Withdrawn
Conditions
Luteal Phase Defect
Interventions
Drug: Placebo
Drug: Progesterone
First Posted Date
2016-11-01
Last Posted Date
2017-12-06
Lead Sponsor
IBSA Institut Biochimique SA
Registration Number
NCT02950948

Efficacy Study of Progesterone Tablet in Post-menopausal Women

Phase 2
Completed
Conditions
Menopause
Interventions
First Posted Date
2016-07-22
Last Posted Date
2018-06-11
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
80
Registration Number
NCT02841137
Locations
🇨🇦

Algorithme Pharma, Mont-Royal, Quebec, Canada

Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries

Phase 4
Completed
Conditions
Athletic Injuries
Interventions
First Posted Date
2014-05-07
Last Posted Date
2018-05-11
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
104
Registration Number
NCT02132247
Locations
🇺🇸

SCORE Physician Alliance, Saint Petersburg, Florida, United States

🇺🇸

Pediatrics and Adolescent Medicine P.A., Marietta, Georgia, United States

🇺🇸

Utah Valley Pediatrics, Orem, Utah, United States

and more 7 locations

Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OA

Phase 3
Completed
Conditions
Knee Osteoarthritis
Interventions
First Posted Date
2014-03-06
Last Posted Date
2017-03-03
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
604
Registration Number
NCT02079727
Locations
🇨🇿

Interni a revmatologicka ordinace, Breclav, Czech Republic

🇧🇪

Unité d'exploration du metabolism osseux, CHU, Polyclinique universitaires L-Brull, Liege, Belgium

🇵🇱

Medica Pro Familia, Warszawa, Poland

and more 13 locations

FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)

Phase 4
Completed
Conditions
Infertility
Interventions
First Posted Date
2013-10-25
Last Posted Date
2019-10-09
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
710
Registration Number
NCT01969201
Locations
🇨🇭

Universitätsklinik für Frauenheilkunde, Bern, Be, Switzerland

🇮🇹

IRCCS San Raffaele, Milan, Italy

🇧🇪

Universitair Ziekenhuis Brussel, Brussels, Belgium

and more 13 locations

Immunogenicity of Repeated Follicle Stimulating Hormone (FSH) Stimulation Cycles

Phase 3
Completed
Conditions
Oocyte Donation
Interventions
First Posted Date
2013-02-07
Last Posted Date
2017-02-09
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
41
Registration Number
NCT01785095
Locations
🇪🇸

Dep.Obstet-Gynec.-Reproduction,Institut Universitari Dexeus, Barcelona, Spain

Injectable Diclofenac for the Prevention of Post-operative Dental Pain

Phase 2
Completed
Conditions
Pain
Interventions
First Posted Date
2012-10-15
Last Posted Date
2014-09-05
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
75
Registration Number
NCT01706588
Locations
🇬🇧

The School of Dentistry University of Birmingham, Birmingham, United Kingdom

Safety and Efficacy Study in in Vitro Fertilisation (IVF) Patients

Phase 3
Completed
Conditions
Infertility
Interventions
First Posted Date
2011-03-11
Last Posted Date
2016-07-22
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
270
Registration Number
NCT01312766
Locations
🇩🇰

Fertility clinic at Hvidovre Hospital, Hvidovre, Copenhagen, Denmark

🇬🇧

Midland Fertility Services, Aldridge, West Midlands, United Kingdom

🇩🇰

Odense Universitetshospital, Odense, Odensee C, Denmark

and more 3 locations

Evaluation of the Efficacy and Safety of Diclofenac HPBCD 75mg/ml in Treatment of Pain Following Dental Surgery

Phase 3
Completed
Conditions
Dental Pain
Interventions
Drug: Diclofenac HPBCD s.c. 75mg/ml
Drug: Voltarol 75mg/3ml i.m.
First Posted Date
2009-07-22
Last Posted Date
2013-01-28
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
142
Registration Number
NCT00943098
Locations
🇬🇧

The School of Clinical Dentistry, The University of Sheffield, Sheffield, United Kingdom

🇬🇧

The School of Dentistry, University of Birmingham, Birmingham, United Kingdom

🇬🇧

Department of oral Surgery; University Dental Hospital, Cardiff, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath